IntelGenx Receives USPTO Notice of Allowance for Loxapine Orange Book Eligible Patent

SAINT LAURENT, Quebec, Feb. 21, 2023 -- IntelGenx Corp.  , a leader in pharmaceutical films, today announced that the United States Patent and Trademark Office has granted a Notice of... | February 21, 2023

Related Keywords

United States ,Canada ,Quebec ,Saint Laurent ,Canadian ,Stephen Kilmer ,Intelgenx Loxapine Versafilm ,Loxapine Versafilm ,Andre Godin ,Horstg Zerbe ,Exchange Commission ,Trademark Office ,Intelgenx Technologies Corp ,Company Or Intelgenx ,Intelgenx Corp ,Securities Exchange ,United States Patent ,Film Oral Dosage Form ,Intelgenx Loxapine ,Looking Information ,Securities Exchange Act ,Securities Act ,United States Securities ,Intelgenx Technologies ,Intelgenx Technologies Corp Stock Exchange ,News ,Information ,Press Release ,Paint ,023 ,Ntelgenx ,Leader ,N ,Harmaceutical ,Oday ,Nnounced ,Hat ,The ,United ,States ,Patent ,End ,Trademark ,Office ,Gas ,Granted ,Otice Igxt Us45822r1014 ,